Jan Anders Hedner

Jan Anders Hedner's AcademicInfluence.com Rankings

Jan Anders Hedner

Philosophy

#6704

World Rank

#9789

Historical Rank

Logic

#3830

World Rank

#5045

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Jan Anders Hedner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jan Anders Hedner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. (2002) (842)
Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. (1993) (713)
Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. (2000) (491)
An independent association between obstructive sleep apnoea and coronary artery disease. (1999) (479)
Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up (2006) (419)
Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? (1988) (388)
Snoring and sleep apnoea in men: association with central obesity and hypertension. (1993) (358)
Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. (1995) (307)
Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. (1996) (287)
Impairment of vascular endothelial function and left ventricular filling : association with the severity of apnea-induced hypoxemia during sleep. (2001) (269)
Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. (1990) (257)
High prevalence of hypertension in sleep apnea patients independent of obesity. (1994) (240)
Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P (1994) (238)
Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. (2001) (226)
Depressed baroreflex sensitivity in patients with obstructive sleep apnea. (1996) (226)
Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. (1993) (219)
Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat (1992) (211)
Night-time symptoms: a forgotten dimension of COPD (2011) (200)
A novel adaptive wrist actigraphy algorithm for sleep-wake assessment in sleep apnea patients. (2004) (199)
Diabetes mellitus prevalence and control in sleep-disordered breathing: the European Sleep Apnea Cohort (ESADA) study. (2014) (199)
Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. (1995) (194)
Recommendations for the management of patients with obstructive sleep apnoea and hypertension (2013) (193)
Sleep‐related breathing disorder is an independent risk factor for uncontrolled hypertension (2000) (189)
Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep (2017) (185)
Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. (1991) (183)
A specific and potent pressor effect of hypoxia in patients with sleep apnea. (1992) (179)
Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. (2002) (178)
Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. (1999) (173)
Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. (1995) (165)
Increased vasoconstrictor sensitivity in obstructive sleep apnea. (2000) (158)
Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case–control study (2006) (154)
Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. (1990) (154)
Validation a portable monitoring device for sleep apnea diagnosis in a population based cohort using synchronized home polysomnography. (2006) (154)
Therapy with nCPAP: incomplete elimination of Sleep Related Breathing Disorder. (2000) (153)
The neuropharmacology of respiratory control. (1982) (151)
CPAP treatment of a population-based sample--what are the benefits and the treatment compliance? (2006) (150)
Sleep apnea-related risk of motor vehicle accidents is reduced by continuous positive airway pressure: Swedish Traffic Accident Registry data. (2015) (150)
Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. (2000) (147)
Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. (2007) (141)
A randomized, double‐blind, placebo controlled, multi‐center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome (2009) (124)
Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study (2014) (120)
Sleep staging based on autonomic signals: a multi-center validation study. (2011) (118)
Clinical Phenotypes and Comorbidity in European Sleep Apnoea Patients (2016) (112)
Reduced hospitalization with cardiovascular and pulmonary disease in obstructive sleep apnea patients on nasal CPAP treatment. (1997) (111)
Impact of self-reported sleep-breathing disturbances on psychosocial performance in the Swedish Obese Subjects (SOS) Study. (1995) (109)
Challenges and perspectives in obstructive sleep apnoea (2018) (104)
The effects of nasal dilation on snoring and obstructive sleep apnea. (1992) (103)
The effect of short‐term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea (2007) (102)
Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia (2000) (99)
The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories (2011) (97)
The diagnostic method has a strong influence on classification of obstructive sleep apnea (2015) (91)
Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study (2002) (90)
Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. (1996) (85)
Reduced α - and β2-Adrenergic Vascular Response in Patients with Obstructive Sleep Apnea (2000) (82)
Sleep apnoea severity independently predicts glycaemic health in nondiabetic subjects: the ESADA study (2014) (79)
Reduction of sleep-disordered breathing after physostigmine. (2003) (76)
The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea (2007) (76)
Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study. (1994) (75)
Blood pressure, cardiac structure and severity of obstructive sleep apnea in a sleep clinic population (2001) (74)
Mean blood pressure, pulse pressure and grade of hypertension in untreated hypertensive patients with sleep-related breathing disorder (2001) (69)
Local effects of substance P on respiratory regulation in the rat medulla oblongata. (1990) (68)
Regulation of breathing in the rat: Indications for a role of central adenosine mechanisms (1982) (67)
Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16-year follow-up. (2010) (67)
Effects of TRH and TRH analogues on the central regulation of breathing in the rat. (1983) (65)
A Double‐Blind Evaluation of Topical Levocabastine, a New Specific H1 Antagonist in Patients with Allergic Conjunctivitis (1985) (64)
Characteristics of insomnia in a primary care setting: EQUINOX survey of 5293 insomniacs from 10 countries. (2010) (63)
Adenosine mechanisms in the regulation of breathing in the rat. (1984) (62)
Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA) (2020) (62)
Occurrence and correlates of sleep disordered breathing in the Australian town of Busselton: a preliminary analysis. (1993) (61)
Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer’s disease (2018) (59)
Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder (2020) (59)
Diurnal and obstructive sleep apnea influences on arterial stiffness and central blood pressure in men. (2005) (59)
Finger plethysmography—a method for monitoring finger blood flow during sleep disordered breathing (2003) (58)
Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort study (2016) (57)
Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database (2018) (56)
Medico-legal implications of sleep apnoea syndrome: driving license regulations in Europe. (2008) (56)
Localization of the central antinociceptive effects of diclofenac in the rat (1992) (56)
Speculations on the interaction between vascular disease and obstructive sleep apnea (1994) (55)
Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo‐Controlled Randomized Withdrawal Study (2019) (55)
The influence of patent foramen ovale on oxygen desaturation in obstructive sleep apnoea (2006) (55)
Central respiratory stimulant effect by thyrotropin in releasing hormone in the rat (1981) (55)
Impaired vigilance and increased accident rate in public transport operators is associated with sleep disorders. (2013) (55)
Management of obstructive sleep apnea in Europe. (2011) (54)
Driving habits and risk factors for traffic accidents among sleep apnea patients – a European multi‐centre cohort study (2014) (54)
Effect of blood volume expansion and sympathetic denervation on plasma levels of atrial natriuretic factor (ANF) in the rat. (1985) (53)
Inhaled Salmeterol and Salbutamol in Asthmatic Patients (1990) (53)
Developmental variations in CSF monoamine metabolites during childhood. (1986) (51)
Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction. (1997) (51)
Obstructive apneic events induce alpha-receptor mediated digital vasoconstriction. (2004) (50)
Hypoxic pressor response, cardiac size, and natriuretic peptides are modified by long-term intermittent hypoxia. (1999) (50)
Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure. (1989) (47)
Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis (2016) (47)
Acetazolamide Reduces Blood Pressure and Sleep-Disordered Breathing in Patients With Hypertension and Obstructive Sleep Apnea: A Randomized Controlled Trial. (2018) (47)
An analysis of the mechanism by which gamma-aminobutyric acid depresses ventilation in the rat. (1984) (46)
Increased plasma levels of atrial natriuretic peptide in patients with congestive heart failure. (1986) (45)
Pharmacological treatment of sleep apnea: current situation and future strategies. (2008) (45)
Interaction of substance P with the respiratory control system in the rat. (1984) (43)
Evidence for a dopamine interaction with the central respiratory control system in the rat. (1982) (42)
Latanoprost and respiratory function in asthmatic patients: randomized, double-masked, placebo-controlled crossover evaluation. (1999) (41)
Daytime consequences of insomnia symptoms among outpatients in primary care practice: EQUINOX international survey. (2010) (41)
Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study (2014) (40)
Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension (2007) (40)
Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity. (2000) (39)
beta-Casomorphins induce apnea and irregular breathing in adult rats and newborn rabbits. (1987) (39)
Local application of somatostatin in the rat ventrolateral brain medulla induces apnea. (1990) (39)
Antagonistic effects of somatostatin and substance P on respiratory regulation in the rat ventrolateral medulla oblongata (1991) (39)
Morphine-sparing effect of diclofenac in cancer pain (1993) (39)
Central, naloxone-reversible antinociception by diclofenac in the rat (1990) (39)
The link between sleep apnea and cardiovascular disease: time to target the nonsleepy sleep apneics? (2001) (39)
Short-term hypoxia reduces arterial stiffness in healthy men (2008) (39)
The diuretic effect of atrial natriuretic peptide (ANP) is dependent on dopaminergic activation. (1986) (38)
Reduced alpha- and beta(2)-adrenergic vascular response in patients with obstructive sleep apnea. (2000) (38)
Diagnostic test evaluation of a nasal flow monitor for obstructive sleep apnea detection in sleep apnea research (2008) (37)
Characterization of the antinociceptive effects of some adenosine analogues in the rat (1986) (37)
Sleep apnoea and quality of life in growth hormone (GH)‐deficient adults before and after 6 months of GH replacement therapy (2006) (37)
Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial (2020) (36)
The Heart Rate Response to Exercise Is Blunted in Patients with Sleep-Related Breathing Disorder (2004) (36)
Substance P in the ventrolateral medulla oblongata regulates ventilatory responses. (1990) (36)
Evidence suggesting a role for substance P in central respiratory regulation in the rat. (1981) (36)
Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial (2020) (36)
Haemodynamic effects and pharmacokinetics of oral d-and l-nebivolol in hypertensive patients (1996) (34)
A double-blind, randomized trial of sabeluzole--a putative glutamate antagonist--in obstructive sleep apnea. (1996) (34)
Atrial peptides, ANP(1-98) and ANP(99-126) in health and disease in an elderly population. (1993) (34)
Acute volume expansion as a physiological stimulus for the release of atrial natriuretic peptides in the rat. (1986) (34)
Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference. (2017) (34)
Attention deficits detected in cognitive tests differentiate between sleep apnea patients with or without a motor vehicle accident. (2015) (34)
Chronic Rhinosinusitis Impairs Sleep Quality: Results of the GA2LEN Study (2017) (33)
For publication in the European Respiratory Journal (2011) (33)
Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial. (2019) (33)
Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS) (2016) (33)
Detection of sleep disordered breathing and its central/obstructive character using nasal cannula and finger pulse oximeter. (2012) (31)
Hemodynamic effects of the use of oral snuff (1992) (31)
A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients. (2009) (30)
Mild Obstructive Sleep Apnea Increases Hypertension Risk Challenging Traditional Severity Classification. (2020) (30)
Substance P-induced respiratory excitation is blunted by delta-receptor specific opioids in the rat medulla oblongata. (1996) (30)
European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea (2021) (29)
Relationship between chemosensitivity, obesity and blood pressure in obstructive sleep apnoea. (1994) (29)
Brainstem localization of a thyrotropin-releasing hormone-induced change in respiratory function (1986) (29)
Low serum concentration of sulfatide and presence of sulfated lactosylceramid are associated with Type 2 diabetes. The Skaraborg Project (2005) (29)
Effects of continuous positive airway pressure treatment and withdrawal in patients with obstructive sleep apnea on arterial stiffness and central BP. (2008) (29)
Increased plasma levels of atrial natriuretic peptide (ANP) in patients with paroxysmal supraventricular tachyarrhythmias. (2009) (28)
Absolute lung size and the sex difference in breathlessness in the general population (2018) (28)
High and Fluctuating Muscle Nerve Sympathetic Activity in the Sleep Apnea Syndrome: A Pathogenetic Mechanism in the Development of Hypertension? (1988) (28)
Plasma Atrial Natriuretic Peptide (Anp) And Maternal Hemodynamic Changes During Normal Pregnancy (1988) (27)
Increased Carbonic Anhydrase Activity is Associated with Sleep Apnea Severity and Related Hypoxemia. (2015) (27)
High prevalence of restless legs syndrome among women with multi‐site pain: A population‐based study in Dalarna, Sweden (2014) (27)
Fixed But Not Autoadjusting Positive Airway Pressure Attenuates the Time‐dependent Decline in Glomerular Filtration Rate in Patients With OSA (2018) (26)
Blunted Renal Response to Atrial Natriuretic Peptide in Congestive Heart Failure Rats Is Reversed by the α2-Adrenergic Agonist Clonidine (1990) (26)
Treatment of postoperative pain with diclofenac in uvulopalatopharyngoplasty. (1992) (26)
The lack of respiratory effects of the ocular hypotensive drug latanoprost in patients with moderate-steroid treated asthma. (1997) (26)
Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers (2005) (26)
Oximeter-based autonomic state indicator algorithm for cardiovascular risk assessment. (2011) (25)
Surgical treatment of the sleep apnea syndrome reduces associated major depression (2000) (25)
Secondary polycythaemia associated with nocturnal apnoea — a relationship not mediated by erythropoietin? (1992) (25)
Carbonic anhydrase, obstructive sleep apnea and hypertension: Effects of intervention (2019) (23)
Detection of cardiovascular risk from a photoplethysmographic signal using a matching pursuit algorithm (2016) (23)
A double-blind, crossover study of Doxazosin and Enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea patients. (2010) (22)
Paroxetine influences respiration in rats: implications for the treatment of panic disorder (2002) (21)
Nonsteroidal antiinflammatory drug modulation of behavioral responses to intrathecal N-methyl-D-aspartate, but not to substance P and amino-methyl-isoxazole-propionic acid in the rat. (1996) (21)
Improvement in Neuropsychological Performance Following Surgical Treatment for Obstructive Sleep Apnea Syndrome (2002) (21)
Pre-operative screening for obstructive sleep apnoea (2017) (21)
Resting and volume-stimulated circulating atrial natriuretic peptide in young normotensive men with positive family histories of hypertension. (1991) (21)
Sleep apnea modifies the long‐term impact of surgically induced weight loss on cardiac function and inflammation (2013) (21)
Vascular function in OSA. (1996) (21)
Nocturnal pulse wave attenuation is associated with office blood pressure in a population based cohort. (2009) (21)
Radioimmunoassay of endothelin in human plasma. (1992) (20)
Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study (2011) (20)
Effects of taurine and a taurine antagonist on some respiratory and cardiovascular parameters. (1983) (19)
Effects of GABA and some GABA analogues on respiratory regulation in the preterm rabbit. (1983) (19)
Stimulation of minor salivary glands by intraoral treatment with the cholinesterase inhibitor physostigmine in man. (2001) (19)
Treatment Options for Sleep Apnoea (2012) (19)
Pitolisant for Daytime Sleepiness in Obstructive Sleep Apnea Patients Refusing CPAP: A Randomized Trial. (2020) (18)
Effects of theophylline on adenosine-induced respiratory depression in the preterm rabbit. (1984) (18)
Relationship between renal sympathetic activity and diuretic effects of atrial natriuretic peptide (ANP) in the rat. (1989) (17)
Clinical presentation of patients with suspected obstructive sleep apnea and self‐reported physician‐diagnosed asthma in the ESADA cohort (2018) (17)
A randomized placebo‐controlled trial of an NMDA receptor antagonist in sleep‐disordered breathing (2005) (17)
A randomised, open‐label, crossover study of the dopamine agonist, pramipexole, in patients with sleep bruxism (2017) (17)
Neuropharmacological aspects of central respiratory regulation. An experimental study in the rat. (1983) (17)
Association Between Estrus Cycle-Related Changes in Respiration and Estrus Cycle-Related Aggression in Outbred Female Wistar Rats (2003) (17)
Sleep habits and their association with mortality during 5-year follow-up after coronary artery bypass surgery (2002) (17)
The use of overnight pulse wave analysis for recognition of cardiovascular risk factors and risk: a multicentric evaluation (2014) (17)
Increased neck soft tissue mass and worsening of obstructive sleep apnea after growth hormone treatment in men with abdominal obesity. (2010) (17)
Cancer prevalence is increased in females with sleep apnoea: data from the ESADA study (2019) (17)
ANP--a cardiac hormone and a putative central neurotransmitter. (1987) (17)
Clusters of sleep apnoea phenotypes: A large pan‐European study from the European Sleep Apnoea Database (ESADA) (2020) (16)
A centrally elicited respiratory stimulant effect by bombesin in the rat. (1985) (16)
Evaluation of a multicomponent grading system for obstructive sleep apnoea: the Baveno classification (2021) (16)
Characterization of adenosine-induced respiratory depression in the preterm rabbit. (1985) (15)
Changes in sleep duration and changes in weight in obese patients: The Swedish Obese Subjects Study (2010) (15)
Substance P, thyrotropin-releasing hormone, and monoamine metabolites in cerebrospinal fluid in sleep apnea patients. (1992) (15)
Hyperlipidaemia prevalence and cholesterol control in obstructive sleep apnoea: Data from the European sleep apnea database (ESADA) (2019) (15)
Appendico-cutaneous fistula. A case report. (1978) (15)
Increase in plasma atrial natriuretic peptides during acute volume expansion in hypertensive man. (2009) (14)
Obstructive sleep apnea in patients with pharyngeal tumours. (1992) (14)
Regulation of systemic vasculature in obstructive sleep apnea syndrome. (2000) (14)
GABA-ergic mechanisms in central respiratory control in the anesthetized rat (2004) (14)
Transient apnea after an enkephalin analogue in the preterm rabbit. (1981) (14)
Hypoventilation and apnoea induced by the substance P antagonist [D-Pro2,D-Trp7,9]-SP in the ventrolateral rat medulla. (1988) (14)
Respiratory stimulant effects by TRH into the mesencephalic region in the rat. (1987) (14)
Changes in cerebrospinal fluid homovanillic acid in children with Ondine's curse (1987) (13)
Haemodynamics and plasma ANP (atrial natriuretic peptide) after acute blood volume expansion in normotensive and spontaneously hypertensive rats. (1988) (13)
Snoring—a common cause of voiding disturbance in elderly men (1996) (13)
Effects of chronic salt loading on plasma atrial natriuretic peptide (ANP) in the spontaneously hypertensive rat. (1987) (13)
Changes in plasma atrial natriuretic peptide — immunoreactivity in patients undergoing coronary artery bypass graft placements (1987) (13)
Measures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50–64 years, the SCAPIS Pilot Study (2017) (13)
Atrial natriuretic peptide and catecholamines in peripheral blood as indicators of cardiac dysfunction in the general population. (1988) (13)
Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP (13)
Acute and chronic treatment with serotonin reuptake inhibitors exert opposite effects on respiration in rats: possible implications for panic disorder (2010) (13)
Drug Therapy in Obstructive Sleep Apnea. (2018) (12)
Respiratory Effects of TRH in Preterm Rabbits (1982) (12)
Insomnia symptoms combined with nocturnal hypoxia associate with cardiovascular comorbidity in the European sleep apnea cohort (ESADA) (2018) (12)
Intracerebroventricular administration of the angiotensin II receptor antagonist saralasin reduces respiratory rate and tidal volume variability in freely moving Wistar rats (2004) (12)
Independent associations between arterial bicarbonate, apnea severity and hypertension in obstructive sleep apnea (2017) (12)
Cerebrospinal fluid concentrations of neurotensin and corticotropin-releasing factor in pediatric patients. (1989) (12)
Atrial natriuretic peptide as a predictor of atrial fibrillation in a male population study. The Study of Men Born in 1913 and 1923. (2014) (12)
Respiratory depression by GABA-ergic drugs in the preterm rabbit. (1980) (11)
Role of the autonomic nervous system in the acute blood pressure elevation during repetitive hypoxic and hypercapnic breathing in rats. (1996) (11)
Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: longitudinal data from the ESADA cohort (2018) (11)
Serotonin depletion increases respiratory variability in freely moving rats: implications for panic disorder. (2003) (11)
Polymorphisms in α- and β-Adrenergic Receptor Genes, Hypertension, and Obstructive Sleep Apnea: The Skaraborg Sleep Study (2010) (11)
Plasma atrial natriuretic peptide and haemodynamics in conscious normotensive and spontaneously hypertensive rats after acute blood volume expansion. (1985) (10)
Association between estrus cycle-related aggression and tidal volume variability in female Wistar rats (2004) (10)
A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea. (2022) (10)
The European Sleep Apnoea Database (ESADA) ERS Clinical Research Collaboration: past, present and future (2018) (9)
Zaleplon provides safe long-term treatment of insomnia in the elderly (1999) (9)
Association between short total sleep time and hypertension: the Skara Sleep Cohort (2013) (9)
Respiratory effects of gamma-hydroxybutyric acid in anesthetized rats (2005) (9)
Rapid Variations in Plasma Atrial Natriuretic Peptide (ANP) During Cardiopulmonary Bypass Surgery (1986) (9)
Perceived sleep deficit is a strong predictor of RLS in multisite pain – A population based study in middle aged females (2017) (9)
Insomnia and cardiorespiratory fitness in a middle-aged population: the SCAPIS pilot study (2018) (9)
Atrial natriuretic peptide during acute treatment of congestive heart failure. (1988) (9)
Chronic pulmonary disease is associated with pain spreading and restless legs syndrome in middle-aged women—a population-based study (2018) (8)
Self-Reported Features of Sleep, Utilization of Medical Resources, and Socioeconomic Position: A Swedish Population Survey (2011) (8)
On the role of atrial natriuretic peptide in cardiovascular regulation in the spontaneously hypertensive rat. (1986) (8)
Endothelin may be pathogenic in systemic sclerosis of the heart. (1997) (8)
Use of the Clinical Global Impression scale in sleep apnea patients - Results from the ESADA database. (2019) (8)
REM Sleep Imposes a Vascular Load in COPD Patients Independent of Sleep Apnea (2017) (7)
Capsaicin and regulation of respiration: Interaction with central substance P mechanisms (2005) (7)
Plasma Atrial Natriuretic Peptide (ANP) in Patients with Mild to Moderate Essential Hypertension (1986) (7)
Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers (2004) (7)
Prolonged Effects of the COVID-19 Pandemic on Sleep Medicine Services—Longitudinal Data from the Swedish Sleep Apnea Registry (2021) (7)
Daytime waking autonomic function and vascular control in OSA (1995) (7)
Overnight pulse wave analysis to assess autonomic changes during sleep in insomnia patients and healthy sleepers (2020) (7)
Sex and age differences in the relationship between sleep duration and hypertension. (2010) (7)
Periodic limb movements during sleep and blood pressure changes in sleep apnoea: Data from the European Sleep Apnoea Database (2019) (6)
Long-term positive airway pressure therapy is associated with reduced total cholesterol levels in patients with obstructive sleep apnea: data from the European Sleep Apnea Database (ESADA). (2020) (6)
Gammahydroxybutyric acid: Central biochemical and behavioral effects in neonatal rats (1985) (6)
Current and Novel Treatment Options for OSA (2022) (6)
Long-term positive airway pressure therapy is associated with reduced total cholesterol levels in patients with obstructive sleep apnea: data from the European Sleep Apnea Database (ESADA). (2020) (6)
Sleep apnoea, hypertension and vascular disease: where are we now? (2007) (6)
Increased Sympathetic Activity as Possible Etiology of Hypertension and Left Ventricular Hypertrophy in Patients with Obstructive Sleep Apnea (1991) (6)
Prediction of cardiovascular risk from peripheral pulse wave (2009) (6)
Morning cortisol and fasting glucose are elevated in women with chronic widespread pain independent of comorbid restless legs syndrome (2018) (6)
Significant relationship between renin suppression and atrial natriuretic peptide (alpha-hANP) during volume loading in hypertensive men. (2009) (6)
Repeated lumbar punctures within 3 days may affect CSF biomarker levels (2019) (6)
Certification of fitness to drive in sleep apnea patients: Are we doing the right thing? (2018) (6)
Sleep deprivation and plasma biomarkers for Alzheimer's disease. (2019) (5)
The European Sleep Apnea Database (ESADA) - Design And First Interim Crossectional Description Of Results From 22 European Sleep Laboratories (2010) (5)
Central respiratory and cardiovascular effects in the rat of some putative neurotransmitter amino acids (1983) (5)
Atrial Natriuretic Peptide in Healthy Children from Birth to Adolescence and in Children with Cardiac Diseases (1986) (5)
The Sleep Revolution project: the concept and objectives (2022) (5)
Chronic rhinosinusitis impairs sleep quality - results of the GA(2)LEN study. (2016) (5)
Parameters of Overnight Pulse Wave under Treatment in Obstructive Sleep Apnea (2016) (5)
Effects of dilevalol, a beta-adrenoceptor antagonist with intrinsic sympathetic activity in asthmatic patients. (1989) (5)
ATRIAL NATRIURETIC FACTOR (ANF) IN PLASMA OF PATIENTS UNDERGOING CARDIOPULMONARY BYPASS SURGERY (1986) (5)
Obstructive Sleep Apnea and Coronary Artery Disease (2007) (5)
Atrial natriuretic peptide (ANP) in relation to blood pressure: a study in middle‐aged men with normal and elevated blood pressure (1989) (5)
STIFFNESS INDEX DERIVED FROM OVERNIGHT PHOTOPLETHYSMOGRAPHY, AND ITS RELATIONS TO AMBULATORY ARTERIAL STIFFNESS INDEX, BLOOD PRESSURE AND CARDIOVASCULAR RISK (2019) (4)
Insomnia is associated with metabolic syndrome in a middle-aged population: the SCAPIS pilot cohort. (2020) (4)
Neuronal and extraneuronal uptake of 3H-noradrenaline in rat portal vein in vitro. (1981) (4)
Evidence for a spinal antinociceptive effect of adenosine in the rat (1984) (4)
A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study (2019) (4)
Acute and long-term changes in plasma levels of atrial natriuretic factor in patients with renal replacement therapy (1990) (4)
Release of atrial natriuretic peptide (alpha-hANP) and circulating noradrenaline in relation to central and renal hemodynamics and sodium output during acute volume load in hypertensive and normotensive men. (2009) (4)
Sleep Deprivation and CSF Biomarkers for Alzheimer Disease (2018) (4)
New pharmacologic agents for obstructive sleep apnoea: what do we know and what can we expect? (2022) (4)
Vascular stiffness determined from a nocturnal digital pulse wave signal: association with sleep, sleep-disordered breathing, and hypertension (2016) (4)
Pharmacological management of sleep-disordered breathing (2010) (4)
[Sleep apnea a risk factor of cardiovascular disease]. (2002) (3)
Turning Over a New Leaf-Pharmacologic Therapy in Obstructive Sleep Apnea. (2022) (3)
Chapter 121 – Coronary Artery Disease and Obstructive Sleep Apnea (2011) (3)
Long-term effects of solriamfetol on quality of life in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnoea (2019) (3)
Nocturnal hypertension--under the cover of darkness. (1995) (3)
Eveningness is associated with sedentary behavior and increased 10-year risk of cardiovascular disease: the SCAPIS pilot cohort (2022) (3)
PLASMA ADENOSINE LEVELS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS FOR CORONARY ARTERY BYPASS GRAFTING (1985) (3)
POSSIBLE INVOLVEMENT OE γ- AMINOBUTYRIC ACID (GABA) AND ENKEPHALINE IN TRANSIENT APNOEA AND RESPIRATORY DEPRESSION IN PRETERM RABBITS (1981) (3)
Correlates of excessive daytime sleepiness in obstructive sleep apnea: Results from the nationwide SESAR cohort including 34,684 patients (2022) (3)
Hypoxia and cardiovascular comorbidity in the ESADA OSA patients with insomnia symptoms (2018) (3)
Mild obstructive sleep apnoea (OSA) and arterial hypertension in the EuropeanSleep Apnoea Database (ESADA) cohort study. (2018) (3)
Plasma noradrenaline and neuropeptide-Y may not be of primary importance in the pathophysiology of cardiac involvement in systemic sclerosis. (1999) (3)
Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. (2021) (3)
Fluid homeostasis and haemodynamics during sodium restriction in hypertensive men. (1985) (3)
Validity of physician-diagnosed COPD in relation to spirometric definitions of COPD in a general population aged 50–64 years – the SCAPIS pilot study (2017) (3)
0601 Long-term Effects Of Solriamfetol On Quality Of Life In Participants With Excessive Daytime Sleepiness Associated With Narcolepsy Or Obstructive Sleep Apnea (2019) (3)
Detection of Sleep Disorders by a Modified Matching Pursuit Algorithm (2009) (3)
0620 A Long-Term Safety and Maintenance of Efficacy Study of Solriamfetol (JZP-110) in the Treatment of Excessive Sleepiness in Subjects with Narcolepsy or Obstructive Sleep Apnea (2018) (2)
Effects of sleep apnea and kidney dysfunction on objective sleep quality in non-dialyzed patients with chronic kidney disease: an ESADA study. (2020) (2)
0693 Effects Of Solriamfetol On 24-hour Blood Pressure Patterns In Participants With Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea (2020) (2)
Beyond the AHI–pulse wave analysis during sleep for recognition of cardiovascular risk in sleep apnea patients (2021) (2)
Current and novel treatment options for obstructive sleep apnoea (2022) (2)
Treatment of Excessive Sleepiness in Patients With OSA: Efficacy and Safety Results of a 6-Week, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Trial of JZP-110 (2017) (2)
Atrial natriuretic peptide and its relation to cardiac dimensions and function in patients with systemic sclerosis. (1994) (2)
Zonisamide reduces obstructive sleep apnea: A randomized placebo-controlled study (2013) (2)
Differential haemodynamic effects of atrial natriuretic peptide (ANP) in normotensive and spontaneously hypertensive rats. (1988) (2)
Atrial natriuretic peptide: relation to left ventricular filling properties in patients with systemic sclerosis. (1994) (2)
Acute and long‐term changes in plasma levels of atrial natriuretic factor in patients with renal replacement therapy (1990) (2)
Plasma atrial natriuretic peptide and blood pressure during chronic salt loading in spontaneously hypertensive rats with right atrial appendectomy (2005) (2)
Central, naloxone-reversible antinocicepeion by diciofenae in the rat (1990) (2)
O0061 Nocturnal heart rate entropy is related to daytime blood pressure (2007) (2)
Chapter 128 – Coronary Artery Disease and Obstructive Sleep Apnea (2017) (2)
Positional obstructive sleep apnea in the European Sleep Apnoea Database (ESADA) study (2018) (2)
Positive airway pressure treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients: Longitudinal data from the ESADA (2019) (2)
Superior hypertension control with betablockade in the European Sleep Apnea Database (2020) (2)
The effect of positive airway pressure on cholesterol in patients with sleep apnea: Data from the European Sleep Apnea Network (ESADA) (2019) (2)
CHANGES IN Meeting Abstracts AFTER THYROIDECTOHY AND PARATHYROIDECTOMY (1984) (2)
Drug therapy for obstructive sleep apnea: From pump to pill? (2019) (1)
Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) adjuvanted vaccine in older adults with chronic obstructive pulmonary disease (COPD) (2018) (1)
Insomnia is associated with metabolic syndrome in a middle-aged population: the SCAPIS pilot cohort. (2020) (1)
Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss: Longitudinal data from the ESADA (2021) (1)
303 PERIPHERAL VASOCONSTRICTION AND NOCTURNAL BLOOD PRESSURE CONTROL IN HYPERTENSIVE SLEEP APNEA PATIENTS (2009) (1)
69. Potent pressor response to hypoxia in awake sleep apnea patients (1991) (1)
Increased arterial standard bicarbonate is associated with hypertension in patients with obstructive sleep apnea – data from the European Sleep Apnea DatAbase (ESADA) (2019) (1)
Safety and efficacy of sulthiame in moderate to severe obstructive sleep apnea: a randomized placebo-controlled parallel-group trial (2021) (1)
Arterial bicarbonate is associated with hypoxic burden and uncontrolled hypertension in obstructive sleep apnea - The ESADA cohort. (2022) (1)
[A snoring plate--an individual preventive device against snoring is not very effective]. (1989) (1)
OSA and cancer in Europe: the European Sleep Apnea Database (ESADA) experience (2017) (1)
Arterial bicarbonate is associated with hypoxic burden and uncontrolled hypertension in obstructive sleep apnea - The ESADA cohort. (2022) (1)
Physiological antagonism between somatostatin and substance P on respiratory regulation in the ventrolateral medulla oblongara of the rat (1988) (1)
Consensus document on the management of patients with obstructive sleep apnea and hypertension. (2010) (1)
Impact of sulthiame on endotypic traits in OSA - a RCT (2022) (1)
Hyperlipidemia Prevalence and Cholesterol Control in OSA: Data from European Sleep Apnea Database (ESADA) (2019) (1)
Effects of solriamfetol treatment on body weight in participants with obstructive sleep apnea or narcolepsy. (2022) (1)
Obstructive sleep apnoea in adult patients post-tonsillectomy. (2020) (1)
Treatment of excessive sleepiness in patients with obstructive sleep apnea: efficacy and safety results of a 6-week, double-blind, placebo-controlled, randomized-withdrawal trial of solriamfetol (JZP-110) (2017) (1)
Acetazolamide reduces blood pressure and sleep disordered breathing in hypertensive obstructive sleep apnoea patients – a randomized controlled trial (2017) (1)
Substance P influences basal ventilation and ventilatory reflexes in the ventrolateral medulla oblongata of the rat (1988) (1)
Chapter 101 – Coronary Artery Disease and Obstructive Sleep Apnea (2005) (1)
Ion concentrations in cerebrospinal fluid in wakefulness, sleep and sleep deprivation in healthy humans (2021) (1)
Mild OSA and arterial hypertension in the European Sleep Apnoea Database cohort study (2019) (1)
[Hypertension and obstructive sleep apnoea]. (2009) (1)
Impact of temperature on obstructive sleep apnoea in three different climate zones of Europe: Data from the European Sleep Apnoea Database (ESADA) (2021) (1)
Nitrazepam iin p patients w with s sleep a apnoea: a d double-blind p placebo-controlled s study (2015) (1)
Plasma Levels of Atrial Natriuretic Peptide (ANP) in SHR During Acute and Chronic Salt Loading (1986) (1)
Pharmacotherapeutic trials for sleep-disordered breathing (2011) (1)
Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea (2019) (1)
Severity Of Sleep Disordered Breathing Is An Independent Predictor Of Glycemic Health: The European Sleep Cohort (ESADA) Study (2012) (1)
The Renal Dopamine System Mediates the Diuretic/Natriuretic Effect of Atrial Natriuretic Peptide (1986) (1)
Overnight pulse propagation time derived from oximetry is associated with daytime blood pressure in patients with sleep apnea (2012) (0)
Serotonin influences respiratory variability in freely moving rats: Implications for panic disorder (2002) (0)
Sleep characteristics and cardio-metabolic comorbidities in the OSA-COPD overlap syndrome: Data from the European Sleep Apnea Database (ESADA) (2022) (0)
LONG SLEEP DURATION AND AMBULATORY BLOOD PRESSURE (2022) (0)
Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine. (2022) (0)
Assessing lapses of attention in sleep disorders (2009) (0)
P005 Long-term safety and efficacy of solriamfetol for excessive daytime sleepiness: an open-label extension randomised withdrawal trial (2019) (0)
Insomnia and cardiorespiratory fitness in a middle-aged population: the swedish cardiopulmonary bioimaging pilot study (2019) (0)
Cardiovascular Effects During Solriamfetol Treatment in Phase 3 Trials in Obstructive Sleep Apnea (2020) (0)
Long-term efficacy of solriamfetol (JZP-110) for excessive daytime sleepiness (EDS) in narcolepsy and obstructive sleep apnea (OSA) (2019) (0)
Health Care Costs Among COPD Patients Are Doubled Compared to A Control Population (2016) (0)
Urine catecholamines in hypertensive men: Whats the role of obstructive apnea? (2000) (0)
Ways to treat and diagnose breathing disorders during sleep and the means to perform the way (2004) (0)
Pulse wave analysis for recognition of cardiovascular risk in sleep apnea patients (2020) (0)
Comment to the Editorial by KS Park and EW Kang "Is only fixed positive airway pressure a robust tool for kidney protection in patients with obstructive sleep apnea?" (2019) (0)
The prevention of sudden spædbarnsdöd (1996) (0)
LONG-TERM EFFECTS OF SOLRIAMFETOL ON EXCESSIVE DAYTIME SLEEPINESS AND FUNCTIONAL OUTCOMES IN PARTICIPANTS WITH OSA (2020) (0)
Prevalence of physician-diagnosed asthma in patients with suspected obstructive sleep apnea syndrome: A cross-sectional analysis of the ESADA database (2015) (0)
0772 Effects Of Solriamfetol On 24-hour Blood Pressure Patterns In Participants With Excessive Daytime Sleepiness Associated With Narcolepsy (2020) (0)
A method for the treatment and diagnosis of respiratory disorders in sövnen by means of zonisamide and means for the method gennemföre (2005) (0)
Are patients referred for sleep studies similar in different parts of Europe (2017) (0)
Determinants of daytime sleepiness in mild obstructive sleep apnoea syndrome. Data from the European Sleep Apnoea Database (ESADA) cohort study. (2018) (0)
[Too large supplies in medicine cabinets of the elderly. Prescription- and discount-systems should be revised]. (1996) (0)
L0059 Menopause and cardiovascular risk factors in sleep apnea (2007) (0)
An agent for the treatment of diagnosis of the Restless Legs Syndrome (1999) (0)
In vivo effects and release mechanisms of atrial natriuretic peptide in experimental animals (1986) (0)
Clinical impact of routine sleep assessment by peripheral arterial tonometry in patients with COPD (2023) (0)
Hyperlipidemia Prevalence and Cholesterol Control in Obstructive Sleep Apnea: Data from the European Sleep Apnea Database (ESADA) (2019) (0)
Erratum to: Is a polysomnographic recording prior to MSLT worth the effort? (2012) (0)
Baseline clusters and the response to positive airway pressure treatment in obstructive sleep apnoea patients: longitudinal data from the European Sleep Apnea Database cohort (2022) (0)
Cardiometabolic impact and symptom profile of obstructivesleep apnea: does gender matter? (2019) (0)
Is a polysomnographic recording prior to MSLT worth the effort? (2011) (0)
Incidence of Restless Legs Syndrome in women with chronic widespread pain and the associations with sleep, mood, and biomarkers (2016) (0)
Changes of complexity of pulse wave signal after elimination of sleep apnea (2013) (0)
Polygraphic parameters do not correlate with obstructive sleep apnoea (OSA) symptoms according to Baveno (2021) (0)
LATANOPROST DOES NOT AFFECT RESPIRATORY FUNCTION IN ASTHMATIC PATIENTS (2000) (0)
National Knowledge-Driven Management of Obstructive Sleep Apnea—The Swedish Approach (2023) (0)
Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA) (2017) (0)
[The CPAP therapy in sleep apnea is a simple treatment tolerated by many]. (1991) (0)
A novel generic algorithm for analysis of the pulse wave signal during sleep (2022) (0)
[Respiratory problems during sleep cause blood gas disorders and illness during the daytime]. (1989) (0)
sleep apnea Increased vasoconstrictor sensitivity in obstructive (2015) (0)
Devices for treatment and diagnosis of Restless Leg Syndrome (1999) (0)
Use of topiramate for the treatment and diagnosis of breathing sövnbesværet udförsel and methods of therapy and diagnosis (2001) (0)
O0071 Impaired attentional alerting in untreated sleep related disordered breathing (2007) (0)
Beneficial effects of telemedicine-based follow up in sleep apnea - a randomized controlled multi-center trial (2022) (0)
The sleepy phenotype in mild Obstructive Sleep Apnoea (OSA) patients: from clinical characteristics to cardiometabolic risk. Data from the European Sleep Apnea Database (ESADA) (2021) (0)
The frequency of COPD exacerbations is related to the comorbidity profile (2016) (0)
METHODS Subject Selection Subjects in the present study were selected from the ongoing Skaraborg Sleep Study , 11 investigating a population-based cohort screened in the Skaraborg Hypertension and Diabetes Project (2006) (0)
Absolute lung size explains the sex difference in breathlessness in the general population (2017) (0)
Lifestyle intervention and pharmaceutical therapies of sleep apnoea (2015) (0)
Contents, Vol. 47, 1985 (1985) (0)
Regional differences in characteristics of patients referred to European sleep centers. Results from the European Sleep Apnea Database (ESADA) (2012) (0)
Certification of fitness to drive in sleep apnea patients – are we doing the right thing? (2018) (0)
Systematic delay in the time to sleep apnea diagnosis in women - data from the Swedish National Sleep Apnea Registry (2018) (0)
Repeated lumbar punctures within 3 days may affect CSF biomarker levels (2019) (0)
Night-to-night variability of PSG-derived physiological endotypic traits in patients with moderate to severe Obstructive Sleep Apnea. (2023) (0)
Ways to treat and diagnose breathing disorders during sleep and means of carrying out the process (1995) (0)
P-31 Growth hormone does not affect cardiac function in men with the metabolic syndrome and obstructive sleep apnea (2008) (0)
P-19 Growth hormone treatment increases obstructive sleep apnea index and neck soft tissue mass in abdominally obese men (2008) (0)
S12.C Beneficial effects of iron sucrose in restless legs syndrome; a randomised, double-blind, placebo-controlled comparison. One year follow-up (2007) (0)
Arterial bicarbonate is associated with hypoxic burden and hypertension in obstructive sleep apnea - the ESADA cohort (2022) (0)
0570 Dose Titration Of Solriamfetol In Participants With Obstructive Sleep Apnea From A 6-week Randomized-withdrawal Trial (2019) (0)
Sleep and cardiometabolic comorbidities in the OSA-COPD overlap syndrome: Data from ESADA (2023) (0)
A novel multicomponent grading system for obstructive sleep apnoea severity applied in the ESADA cohort (2020) (0)
Sulthiame reduces loop gain and increases the arousal threshold - Insights from a RCT in patients with moderate to severe OSA (2022) (0)
Prevalence and characteristics of insomnia phenotype in mild sleep apnoea patients from the ESADA study population (2017) (0)
Night-to-night variability of automatically derived physiological endotypic traits in patients with Obstructive Sleep Apnea (2022) (0)
Effects of sympathetic inhibition in rats with chronic ischemic heart failure resistant to ANP (1990) (0)
[Atrial natriuretic factor--a new bioactive peptide from cardiac atria]. (1985) (0)
A process for the treatment and diagnosis of sleep disordered breathing with zonisamide and medium for performing the method (2005) (0)
Reply to Chen et al. (2022) (0)
Reduced hypoxic burden following carbonic anhydrase inhibition in obstructive sleep apnea – a randomized placebo-controlled study (2021) (0)
Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: Longitudinal data from the European Sleep Apnea Database (ESADA) (2017) (0)
Reply to: Carbonic Anhydrase Inhibitors: A New Dawn for the Treatment of OSA. (2022) (0)
Evaluation of a new 'anti-snoring device'. (1989) (0)
Clinical characteristics and positive airway pressure adherence among elderly European sleep apnoea patients from the ESADA cohort (2023) (0)
O0059 The influence of patent foramen ovale on oxygen desaturation in obstructive sleep apnoea (2007) (0)
The placebo effect in pharmacological treatment of obstructive sleep apnea, a systematic review and meta-analysis. (2023) (0)
Is it possible to check whether two measurements was performed on the same patient using pulsoximetric pulse wave signal characteristics (2015) (0)
P-70 THE EFFECT OF 12-MONTH GROWTH HORMONE TREATMENT ON OBSTRUCTIVE SLEEP APNEA IN ABDOMINALLY OBESE MEN (2006) (0)
Obstructive sleep apnea and associations with lung function (2022) (0)
238-244; SA Aug02 Misc (2002) (0)
The Effect of CPAP Therapy in Sleep Apnea Patients on Single Parameters of the Nocturnal Pulse Wave Analysis (2018) (0)
Clusters of sleep apnea phenotypes: A European perspective from the ESADA database (2019) (0)
The sleepy phenotype in mild OSA patients: characteristics and their cardiometabolic risk. Data from the European Sleep Apnea Data Base (ESADA) (2020) (0)
Prediction of cardiovascular risk from nocturnal pulse wave signal using the autonomic state indicator technology (2012) (0)
Medications and Their Effects on Sleep and Wake. (2018) (0)
Blood pressure reduction following treatment with positive airway pressure in sleep apnea: data from the European Sleep Apnea Database (2020) (0)
[Scopolamine against hypersalivation]. (1993) (0)
Can a composite analysis of autonomic and vascular signals predict cardiovascular risk? – The ASI approach (2012) (0)
Residual daytime sleepiness (RES) in CPAP-treated obstructive sleep apnea (OSA) patients in the European Sleep Apnea Database (ESADA) (2021) (0)
0641 Effects of Weight Loss During Long-Term Solriamfetol Treatment on Cardiometabolic Indices (2020) (0)
Prediction of cardiovascular risk from nocturnal pulse wave signal – Results from the ASIC multi center study (2011) (0)
OBSTRUCTIVE SLEEP APNEA IS AN INDEPENDENT PREDICTOR OF ARTERIAL STIFFNESS IN HYPERTENSIVE PATIENTS (2021) (0)
S22 Severity of sleep disordered breathing independently predicts metabolic dysfunction in a large population of severely obese subjects: the esada study (2016) (0)
Independent associations between arterial bicarbonate, apnea severity and hypertension in a sleep apnea cohort (2016) (0)
CHANGES IN RESPIRATION AFTER THYROIDECTOHY AND PARATHYROIDECTOMY (1984) (0)
Detection of cardiovascular risk from a photoplethysmographic signal using a matching pursuit algorithm (2015) (0)
Use of topiramate for the treatment and diagnosis of respiratory disorders during sleep, and means for carrying out the treatment and diagnosis (2001) (0)
Modified Matching Pursuit algorithm for application in sleep screening (2009) (0)
Obstructive sleep apnea and objective sleep quality in non-dialyzed patients with chronic kidney disease: an ESADA study (2019) (0)
S50.1 Symposium summary (2007) (0)
Sulthiame induced carbonic anhydrase inhibition is associated with improvement of nocturnal oxygenation in OSA patients (2022) (0)
Reduction iin s sympathetic a activity a after llong-term C CPAP ttreatment in s sleep a apnoea: c cardiovascular iimplications (1995) (0)
P341 Sympathetic activity and renin–angiotensin–aldosterone system in normotensive men with obstructive sleep apnea before and 3 weeks after CPAP treatment (2006) (0)
Pulse wave analysis but not polysomnography recognizes sleep apnoea patients with increased cardiovascular risk (2017) (0)
Reference values for mean overnight saturation in sleep apnoea – the European Sleep Apnoea Database (ESADA) (2020) (0)
Poster presentations (2007) (0)
A sleep apnea related risk of vehicle accident is reduced by CPAP - Swedish traffic accident data acquisition (STRADA) registry (2014) (0)
Daridorexant (Act-541468), a new dual orexin receptor antagonist, for the treatment of insomnia disorder: a randomized, double-blind, placebo-controlled, active-reference phase 2 study (2019) (0)
Eveningness is associated with sedentary behavior and increased cardiovascular risk – data from the SCAPIS pilot cohort (2022) (0)
Late-breaking abstract: Nocturnal intermittent hypoxia strongly predicts systemic hypertension in the European Sleep Apnoea Cohort Study (2011) (0)
Long-Term Maintenance of Efficacy and Safety of Pitolisant in the Treatment of Residual Sleepiness in Patients With Obstructive Sleep Apnoea (2023) (0)
Effect of sulthiame on cardiopulmonary coupling assessed sleep quality in OSA patients – a RCT (2022) (0)
143 Obstructive sleep apnea as a health risk factor (2006) (0)
Changes in cognitive function and daytime sleepiness in patients with chronic heart failure and Cheyne-Stokes respiration with adaptive servo ventilation treatment (2023) (0)
Means to treat and diagnose restless legs syndrome. (1999) (0)
0375 A Novel Dual Orexin Receptor Antagonist (ACT-541468) to Treat Insomnia: A Randomized, Double-Blind, Placebo-Controlled, Active-Reference Phase 2 Study (2019) (0)
[OP.8B.01] PERIODIC LIMB MOVEMENT DURING SLEEP, SLEEP RELATED BREATHING DISORDERS AND HYPERTENSION IN THE ESADA COHORT (2016) (0)
Erratum: Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU (2020) (0)
Professional and frequent driving habits detected in the European Sleep Apnea Database (ESADA) - Call for a safety alert (2012) (0)
CPAP device for using a neural network (2001) (0)
Erratum to "Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder". (2020) (0)
Blood pressure reduction following treatment with positive airway pressure in sleep apnea – data from the ESADA (2020) (0)
airway resistance in sleeping humans An induced blood pressure rise does not alter upper (2015) (0)
Blunted renal effects of atrial natriuretic peptide in rats with chronic ischemic heart failure (1988) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jan Anders Hedner?

Jan Anders Hedner is affiliated with the following schools:

Jan Anders Hedner's Academic­Influence.com Rankings

Why Is Jan Anders Hedner Influential?

Jan Anders Hedner's Published Works

Published Works

What Schools Are Affiliated With Jan Anders Hedner?

Jan Anders Hedner's AcademicInfluence.com Rankings